Citigroup maintains the latest target price of the Charles River rating at $ 215.00

  () CITIGROUP on December 11 maintains the Charles River rating as neutral,hot topic with the latest target price of $ 215.00.

  The Charles River issued a third quarterly report on November 8. As of September 30, 2023, the company's operating income was US $ 3.116 billion, net profit was 291 million US dollars, and the basic earnings per share were $ 5.62.

  Charles River Laboratories International, Inc. has been operating in 1947. Since then, it has experienced several business structures.The Charles River Laboratory International Co., Ltd. was established in 1994 and completed its first public offering in 2000.The company is a global leading supplier to accelerate early drug discovery and development solutions.The company's business focuses on biology in the body; the company's product portfolio includes a research model that enables drug discovery and development in the body.The company's products and services, through its global infrastructure and deep scientific knowledge support, allow customers to expose many early life scientific research challenges.